Article: Ovarian Hyperstimulation Syndrome – It’s Time to Reverse the Trend

Ovarian Hyperstimulation Syndrome – It’s Time to Reverse the Trend
By Dr. Geeta Nargund | BioNews | Dec. 5, 2016

screen-shot-2016-12-12-at-2-58-45-pmIn this commentary, Dr. Geeta Nargund at CREATE Fertility, discusses the increase in ovarian hyperstimulation syndrome (OHSS) reported by fertility clinics in the United Kingdom.

In the author’s opinion, a report published by the Human Fertilization and Embryology Authority (HFEA) “obfuscates” real data – a 40 percent rise in hospital admissions with severe OHSS. She suggests the HFEA prioritize this “alarming statistic” and focus on reversing the trend, offering the following recommendations: a reduced dose of stimulation followed by GnRH agonist to trigger ovulation, with an option of cryopreservation of all embryos; and abandoning the use of the “long downregulation” protocol, employed in many IVF treatment cycles, and a switch to antagonist cycles.

In line with others in the field, Nargund also emphasizes the need for informed consent – placing the responsibility for this on providers – and rigorous documentation of the effects of stimulation protocols (including the drugs and dosages used).

Read the full commentary >